Back to search

A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

NCT04439799

PHASE4INTERVENTIONAL
University of Miami
81 participants
Started 2020-08-07 · Completed 2023-02-09
Status: Completed (as of 12-23-2025)

Conditions

Hypogonadism, Male

Linked Papers (from SciSciNet-V2)

Total Papers11
Background
3
Result
0
Derived
0
Unknown
8

Total Citations Per Year

Brief Summary

The purpose of this study is to evaluate changes in vascular parameters and the prevalence of side effects in subjects receiving 1 cc (200mg) every 2 weeks intramuscular (IM) of Testosterone Cypionate versus subjects receiving 11mg three times daily (TID) Natesto to participant with clinical hypogonadism.